Lynda M. Vrooman

Postinduction Dexamethasone and Individualized Dosing of <i>Escherichia Coli</i> L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01

Lynda M. Vrooman, Kristen E. Stevenson, Jeffrey G. Supko et al. · Journal of Clinical Oncology · 2013 · 315 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman et al. · The Lancet Oncology · 2015 · 240 citations

Medicine, Oncology, Pediatrics +8

Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation

Inge M. van der Sluis, Lynda M. Vrooman, Rob Pieters et al. · Haematologica · 2016 · 239 citations · Full text

Life Sciences, Immunology, Oncology +11

<i>Erwinia</i> asparaginase after allergy to <i>E. coli</i> asparaginase in children with acute lymphoblastic leukemia

Lynda M. Vrooman, Jeffrey G. Supko, Donna Neuberg et al. · Pediatric Blood & Cancer · 2009 · 159 citations · Full text

Medicine, Oncology, Pediatrics +11

Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study

Benjamin Ole Wolthers, Thomas Leth Frandsen, André Baruchel et al. · The Lancet Oncology · 2017 · 130 citations

Medicine, Oncology, Pediatrics +12